POTS: Salt and Fluid Loading, the First-Line Non-Drug Treatment

The commonly recommended everyday starting range is roughly 3 to 5 grams of additional sodium a day and roughly 2 to 3 liters of fluid a day, spread through the day rather than taken all at once. Some guidance goes higher, up to about 10 grams, with physician input. The 2015 Heart Rhythm Society consensus names sodium and fluid loading as first-line non-drug therapy on expert consensus rather than randomized-trial proof, and Raj's own CASA-POTS trial is still testing the optimal dose, so these are ranges, not one settled number. Sodium loading needs supervision or is contraindicated with high blood pressure, heart failure, kidney disease, or in pregnancy. Evidence grade: limited.

This is education only. A beta blocker such as low-dose propranolol is one of the medications a clinician may consider for POTS symptom control. Raj's own 2009 randomized crossover trial found a low dose reduced standing tachycardia and symptoms, while a higher dose did not help more and looked worse, which is why less is more is the finding people quote. It was a single-center, acute-dosing study in roughly 54 patients, not a long-term outcome trial. This is information only: whether to start a beta blocker is a prescription decision made with your clinician, never a self-directed add. Evidence grade: moderate for the acute low-dose effect.

The diagnostic pattern is a sustained heart-rate increase of at least 30 beats per minute within 10 minutes of standing in adults (at least 40 beats per minute in adolescents), without a drop in blood pressure that would indicate orthostatic hypotension, with symptoms lasting three months or more, and with other causes ruled out. A clinician can check this with a bedside active stand test or a tilt-table test. A heart-rate number on its own is not a diagnosis; only a clinician diagnoses POTS.

Many people improve substantially over time, and some do see their symptoms go away, but there is no guarantee and no cure claim. Kimpinski's 2012 one-year prospective follow-up of 58 patients found symptoms improved in most, and more than a third no longer met tilt-table criteria at one year, described as a relatively favourable prognosis in most patients. The honest limits: it was a small, not-post-COVID study with mild autonomic dysfunction at baseline. Many adolescents improve over years with conventional treatment, and the long-term prognosis for post-COVID POTS specifically is not yet well established. Evidence grade: limited, based on small observational follow-up studies.

Heat makes POTS worse because warming the skin opens the blood vessels near the surface, which increases pooling and reduces the blood returning to the heart, so standing gets harder. That is why a hot shower, a hot day, or a hot room can trigger symptoms. Practical countermeasures: sit on a shower stool, use cooler or lukewarm water, pre-cool before heat exposure, and use a cooling vest or cold packs in hot weather. The direct cooling-vest evidence is indirect: the Ganio study used 8 healthy adults after bed rest with an active water-perfusion cooling suit, not POTS patients with a passive commercial vest, so it shows the mechanism, not proof that a shop-bought vest treats POTS. Evidence grade: limited.